Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PI 18:0_21:3)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003945 AN006485 Lipidomics characterization of A375 and A375-VR melanoma cells treated with ranolazine and sampled longitudinally. Cultured cells Human Cancer University of Colorado Denver LC-MS
ST003664 AN006021 Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. T-cells Mouse Cancer University of Chicago LC-MS
ST002747 AN004457 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Human CZ Biohub LC-MS
ST002747 AN004457 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Rickettsia parkeri CZ Biohub LC-MS
ST002145 AN003511 The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy Cultured cells Mouse Diabetes University of Texas MD Anderson Cancer Center LC-MS
ST002145 AN003512 The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy Cultured cells Mouse Diabetes University of Texas MD Anderson Cancer Center LC-MS
ST002070 AN003375 Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Cultured cells Human Cancer Ohio State University LC-MS
  logo